The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Identification, classification, and expression of RAGE gene splice variants
Abstract
The receptor for advanced glycation end‐products (RAGE) is a single‐transmembrane, mul tiligand receptor of the immunoglobulin superfamily. RAGE up‐regulation is implicated in numerous patho logical states including vascular disease, diabetes, can cer, and neurodegeneration. The understanding of the regulation of RAGE is important in both disease patho genesis and normal homeostasis. Here, we demonstrate the characterization and identification of human RAGE splice variants by analysis of RAGE cDNA from tissue and cells. We identified a vast range of splice forms that lead to changes in the protein coding region of RAGE, which we have classified according to the Human Gene Nomenclature Committee (HGNC). These resulted in protein changes in the ligand‐binding domain of RAGE or the removal of the transmembrane domain and cytosolic tail. Analysis of splice variants for premature termination codons reveals~50% of identified variants are targeted to the nonsense‐mediated mRNA decay pathway. Expression analysis revealed the RAGE_v1 variant to be the primary secreted soluble isoform of RAGE. Taken together, identification of functional splice variants of RAGE underscores the biological diversity of the RAGE gene and will aid in the under standing of the gene in the normal and pathological state.—Hudson, B. I., Carter, A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., Grant, P. J., Schmidt, A. M. Identification, classification, and expression of RAGE gene splice variants. FASEB J . 22, 1572–1580 (2008)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hall, T. A. (1999) · Nucleic Acids Symposium Series · doi:10.14601/phytopathol_mediterr-14998u1.29 · Cited by 38,297
Guo, W., Cheng, Y., & Deng, X. (2002) · Plant Cell Reports · doi:10.1007/s00299-001-0399-7 · Cited by 2,227
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
Self-citationNeeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Self-citationKozak, M. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.20.5233 · Cited by 1,242
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Self-citationPark, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104
Self-citationKislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Du Yan, S., Hofmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 869
Self-citationYONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal · doi:10.1042/bj20021371 · Cited by 716
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
Self-citationNonsense-mediated decay approaches the clinic
Holbrook, J. A., Neu-Yilik, G., Hentze, M. W., & Kulozik, A. E. (2004) · Nature Genetics · doi:10.1038/ng1403 · Cited by 596
Guidelines for Human Gene Nomenclature
Wain, H. M., Bruford, E. A., Lovering, R. C., Lush, M. J., Wright, M. W., & Povey, S. (2002) · Genomics · doi:10.1006/geno.2002.6748 · Cited by 500
Regulation of gene expression by alternative promoters
Ayoubi, T. A. Y., & Van De Yen, W. J. M. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.4.8647344 · Cited by 387
Falcone, C., Emanuele, E., D’Angelo, A., Buzzi, M. P., Belvito, C., Cuccia, M., & Geroldi, D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160342.20342.00 · Cited by 377
Koyama, H., Shoji, T., Yokoyama, H., Motoyama, K., Mori, K., Fukumoto, S., Emoto, M., Shoji, T., Tamei, H., Matsuki, H., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000190660.32863.cd · Cited by 313
Geroldi, D., Falcone, C., & Emanuele, E. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777585013 · Cited by 249
Sugaya, K., Fukagawa, T., Matsumoto, K.-I., Mita, K., Takahashi, E.-I., Ando, A., Inoko, H., & Ikemura, T. (1994) · Genomics · doi:10.1006/geno.1994.1517 · Cited by 242
Emanuele, E., D’Angelo, A., Tomaino, C., Binetti, G., Ghidoni, R., Politi, P., Bernardi, L., Maletta, R., Bruni, A. C., & Geroldi, D. (2005) · Archives of Neurology · doi:10.1001/archneur.62.11.1734 · Cited by 218
Basta, G., Sironi, A. M., Lazzerini, G., Del Turco, S., Buzzigoli, E., Casolaro, A., Natali, A., Ferrannini, E., & Gastaldelli, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2559 · Cited by 205
Geroldi, D., Falcone, C., Emanuele, E., D'Angelo, A., Calcagnino, M., Buzzi, M. P., Scioli, G. A., & Fogari, R. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000177535.45785.64 · Cited by 188
Schlueter, C., Hauke, S., Flohr, A. M., Rogalla, P., & Bullerdiek, J. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2003.08.008 · Cited by 157
RAGE and Soluble RAGE: Potential Therapeutic Targets for Cardiovascular Diseases
Koyama, H., Yamamoto, H., & Nishizawà, Y. (2007) · Molecular Medicine · doi:10.2119/2007-00087.koyama · Cited by 156
Decreased Endogenous Secretory Advanced Glycation End Product Receptor in Type 1 Diabetic Patients
Katakami, N., Matsuhisa, M., Kaneto, H., Matsuoka, T., Sakamoto, K., Nakatani, Y., Ohtoshi, K., Hayaishi-Okano, R., Kosugi, K., Hori, M., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2716 · Cited by 155
Malherbe, P., Richards, J. G., Gaillard, H., Thompson, A., Diener, C., Schuler, A., & Huber, G. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00174-6 · Cited by 143
Park, I. H. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.11.027 · Cited by 139
Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease
Hudson, B. I., Harja, E., Moser, B., & Schmidt, A. M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000164804.05324.8b · Cited by 112
Self-citationRAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease
Hudson, B. I., & Schmidt, A. M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032992.75423.9b · Cited by 79
Self-citationSplice variants of the receptor for advanced glycosylation end products (RAGE) in human brain
Ding, Q., & Keller, J. N. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.059 · Cited by 77
Regulation of growth and dissemination of a human lymphoma by CD44 splice variants
Bartolazzi, A., Jackson, D. G., Bennett, K., Aruffo, A. A., Dickinson, R. B., Shields, J., Whittle, N., & Stamenkovic, I. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.4.1723 · Cited by 76
Development of an ELISA for esRAGE and its application to type 1 diabetic patients
Sakurai, S., Yamamoto, Y., Tamei, H., Matsuki, H., Obata, K., Hui, L., Miura, J., Osawa, M., Uchigata, Y., Iwamoto, Y., et al. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.12.013 · Cited by 68
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
HMGB1 and RAGE in Inflammation and Cancer
Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132603 · Cited by 1,436
Sparvero, L. J., Asafu-Adjei, D., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A. A., Zeh, H. J., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-17 · Cited by 622
Chronic Inflammation in Cancer Development
Multhoff, G., Molls, M., & Radons, J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00098 · Cited by 576
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., & Münch, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.016 · Cited by 524
Metadata
- Authors
- Hudson, B. I., Carter, A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., Grant, P. J., & Schmidt, A. M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-12-18
- Volume
- 22
- Issue
- 5
- Pages
- 1572-1580
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2118385532
- Cited by
- 360
- References
- 30
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.